# Neurological Outcome After SARS-CoV-2 Infection

> **NCT05025839** · — · UNKNOWN · sponsor: **Medical University Innsbruck** · enrollment: 355 (estimated)

## Conditions studied

- SARS-CoV-2
- Post-acute COVID-19 Syndrome

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05025839
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-07
- **Primary completion:** 2023-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 355 (ESTIMATED)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05025839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05025839, "Neurological Outcome After SARS-CoV-2 Infection". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT05025839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*